The Eye and The Chip

11th World Research Congress on the Relationship Between

Neurobiology and Nano-Electronics Focusing on Artificial Vision

November 10-12, 2019

The Henry Hotel, Dearborn, MI

THE EYE AND THE CHIP 2019

 

Date: November 10-12, 2019

Place: The Henry Hotel, Dearborn, MI

Organizing Committee:

Lauren Ayton, Ph.D., University of Melbourne, Melbourne, Australia

David Goldman, M.D., M.B.A., Detroit Institute of Ophthalmology, Department of Ophthalmology, Henry Ford Health System, Detroit, MI
Philip C. Hessburg, M.D., Detroit Institute of Ophthalmology, Department of Ophthalmology, Henry Ford Health System, Detroit, MI

Roseanne Horne, Detroit Institute of Ophthalmology, Department of Ophthalmology, Henry Ford Health System, Detroit, MI

Philip C. Hessburg, M.D., Medical Director, Detroit Institute of Ophthalmology, HFHS, Detroit, MI

Edward R. O’Malley, M.D., Detroit Institute of Ophthalmology, Department of Ophthalmology, Henry Ford Health System, Detroit, MI

Daniel Rathbun, Ph.D., Department of Ophthalmology, Henry Ford Health System, Detroit, MI
Joseph Rizzo, M.D., Neuro-Ophthalmology Department, Harvard Medical School, Massachusetts Eye & Ear Infirmary, Boston, MA

Edward R. O’Malley, M.D., Former Physician-in-Charge Henry Ford Medical Center – Cottage, Grosse Pointe Farms, MI
Philip Troyk, Ph.D., Illinois Institute of Technology, Chicago, IL

James Weiland, Ph.D, University of Michigan, Ann Arbor, MI

 

 

Congress Objectives


At the end of the three-day world congress attendees will:

• Have a clear understanding of which blind patients will benefit from a visual neuro-prosthetic device

• Have reviewed progress in the field of visual neuro-prosthetic device development and challenges of surgical implementation

• Will know how nano-electronic visual neuroprosthetic devices compare with other artificial vision initiatives

• Have viewed the development process of a complex medical device, and will recognize the role played by the USFDA in bringing forth safe and effective medical devices

• Be fully aware of which patients will benefit from a device within the eye, and which patients will benefit only by a device interfacing directly with the visual cortex of the brain

• Have formed additional collaborative relationships which will serve to accelerate the process of device development and implantation

 

If you have questions or interest in supporting this congress by attendance, abstract submission or financially, please contact:

Roseanne Horne at 313-936-1968 or Rhorne1@hfhs.org

Site Design by Dynasty Media Network